← Back
$TNDM All transactions

TANDEM DIABETES CARE INC

M

$ Value

$0

Shares

23,929

Price

$0

Filed

May 19

Insider

Name

Sheridan John F

Title

PRESIDENT & CEO

CIK

0001365369

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-15

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

108,479

Footnotes

The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 18, 2024, through May 15, 2025. This transaction is also exempt under Rule 16b-3(c). | Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. | Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). | Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. | RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. | Awarded on May 25, 2022 pursuant to the 2013 Plan. | RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. | Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). | Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. | RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. | Awarded on May 23, 2024 pursuant to the 2023 Plan. | RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.

Filing Info

Accession No.

0001438133-25-000085

Form Type

4

Issuer CIK

0001438133

Sheridan John F's History

Date Ticker Type Value
2026-02-17 TNDM M $0
2026-02-17 TNDM F $37K
2026-02-17 TNDM M $0
2026-02-17 TNDM F $45K
2026-02-17 TNDM M $0
2026-02-17 TNDM M $0
2025-11-17 TNDM M $0
2025-11-17 TNDM F $52K
2025-11-17 TNDM M $0
2025-11-17 TNDM F $57K

Other Insiders at TNDM (90d)

Insider Bought Sold Last
Sheridan John F
PRESIDENT & CEO
2026-02-17
Carpenter Rick
Chief Technology Officer
2026-02-17
Morrison Susan
EVP & Chief Admin. Officer
2026-02-17
Vosseller Leigh
EVP & CHIEF FINANCIAL OFFICER
2026-02-17
Kyrillos Jean-Claude
EVP & Chief Operating Officer
2026-04-15
Gasser Elizabeth Anne
EVP, Chief Strategy Officer
2026-02-17
Hansen Shannon Marie
EVP & Chief Legal Officer
2026-02-17
Novara Mark David
EVP & CHIEF COMMERCIAL OFFICER
$4K 2026-03-17